Annual Financials for UnitedHealth Group Inc.
Fiscal year is January-December. All values USD millions. |
2016 | 2017 | 2018 | 2019 | 2020 |
5-year trend |
Sales/Revenue |
185.5B | 201.16B | 226.25B | 242.16B | 257.14B | |
Premiums Earned |
144.12B | 158.45B | 178.09B | 189.7B | 201.48B | |
Total Investment Income |
662M | - | - | - | 1.5B | |
Realized Gains (Losses) |
211M | - | - | - | - | |
Other Operating Income |
40.56B | 42.71B | 48.16B | 52.46B | 54.16B | |
Sales Growth |
- | 8.44% | 12.47% | 7.03% | 6.19% | |
Losses, Claims & Reserves |
117.04B | 130.04B | 145.4B | 156.44B | 159.4B | |
Losses, Benefits & Adjustments |
117.04B | 130.04B | 145.4B | 156.44B | 159.4B | |
Losses, Claims & Reserves Growth |
- | 11.11% | 11.82% | 7.59% | 1.89% | |
Loss Ratio |
- | - | - | - | 79.11% | NA |
|
2016 | 2017 | 2018 | 2019 | 2020 |
5-year trend |
Selling, General & Admin. Expenses & Other |
54.87B | 55.91B | 63.5B | 66.03B | 75.34B | |
Selling, General & Admin. Expenses |
30.46B | 31.8B | 36.5B | 37.91B | 44.6B | |
Other Selling, General & Admin. Expense |
- | - | - | - | - | |
Underwriting & Commissions |
- | - | - | - | - | |
Other Operating Expense |
24.42B | 24.11B | 27B | 28.12B | 30.75B | |
SGA Growth |
- | 1.90% | 13.57% | 3.98% | 14.10% | |
Operating Income Before Interest Expense |
13.59B | 15.21B | 17.34B | 19.69B | 22.41B | |
Interest Expense, Net of Interest Capitalized |
1.07B | 1.19B | 1.4B | 1.7B | 1.66B | |
Interest Expense (excl. Interest Capitalized) |
1.07B | 1.19B | 1.4B | 1.7B | 1.66B | |
Interest Capitalized |
- | - | - | - | - | |
Operating Income After Interest Expense |
12.53B | 14.02B | 15.94B | 17.98B | 20.74B | |
Operating Income Growth |
- | 11.90% | 14.04% | 13.50% | 13.82% | |
Non-Operating Income (Expense) |
- | - | - | - | - | |
Miscellaneous Non Operating Expense |
- | - | - | - | - | |
Equity in Affiliates (Pretax) |
- | - | - | - | - | |
Unusual Expense |
- | - | - | - | - | |
Pretax Income |
11.86B | 14.02B | 15.94B | 17.98B | 20.74B | |
Pretax Income Growth |
- | 18.21% | 13.70% | 12.78% | 15.36% | |
Income Taxes |
4.79B | 3.2B | 3.56B | 3.74B | 4.97B | |
Income Tax - Current - Domestic |
4.71B | 3.91B | 3.12B | 2.95B | - | |
Income Tax - Current - Foreign |
- | 254M | 404M | 564M | - | |
Income Tax - Deferred - Domestic |
81M | (965M) | 42M | 230M | - | |
Income Tax - Deferred - Foreign |
- | - | - | - | - | |
Income Tax Credits |
- | - | - | - | - | |
Equity in Affiliates |
- | - | - | - | - | |
Other After Tax Income (Expense) |
- | - | - | - | - | |
Consolidated Net Income |
7.07B | 10.82B | 12.38B | 14.24B | 15.77B | |
Minority Interest Expense |
56M | 265M | 396M | 400M | 366M | |
Net Income |
7.02B | 10.56B | 11.99B | 13.84B | 15.4B | |
Net Income Growth |
- | 50.46% | 13.53% | 15.46% | 11.30% | |
Net Margin |
- | - | - | - | 5.99% | NA |
Extraordinaries & Discontinued Operations |
- | - | - | - | - | |
Extra Items & Gain/Loss Sale Of Assets |
- | - | - | - | - | |
Cumulative Effect - Accounting Chg |
- | - | - | - | - | |
Discontinued Operations |
- | - | - | - | - | |
Net Income After Extraordinaries |
7.02B | 10.56B | 11.99B | 13.84B | 15.4B | |
Preferred Dividends |
- | - | - | - | - | |
Net Income Available to Common |
7.02B | 10.56B | 11.99B | 13.84B | 15.4B | |
EPS (Basic) |
7.37 | 10.95 | 12.45 | 14.55 | - | |
EPS (Basic) Growth |
- | 48.59% | 13.64% | 16.92% | - | |
Basic Shares Outstanding |
952M | 964M | 963M | 951M | - | |
EPS (Diluted) |
7.25 | 10.72 | 12.19 | 14.33 | 16.03 | |
EPS (Diluted) Growth |
- | 47.87% | 13.76% | 17.49% | 11.88% | |
Diluted Shares Outstanding |
968M | 985M | 983M | 966M | 961M | |